119 related articles for article (PubMed ID: 37655756)
1. Gamma-patterned sensory stimulation reverses synaptic plasticity deficits in rat models of early Alzheimer's disease.
Yang Y; Ondrejcak T; Hu NW; Islam S; O'Rourke E; Reilly RB; Cunningham C; Rowan MJ; Klyubin I
Eur J Neurosci; 2023 Sep; 58(6):3402-3411. PubMed ID: 37655756
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents.
Qi Y; Klyubin I; Harney SC; Hu N; Cullen WK; Grant MK; Steffen J; Wilson EN; Do Carmo S; Remy S; Fuhrmann M; Ashe KH; Cuello AC; Rowan MJ
Acta Neuropathol Commun; 2014 Dec; 2():175. PubMed ID: 25540024
[TBL] [Abstract][Full Text] [Related]
3. Rapidly reversible persistent long-term potentiation inhibition by patient-derived brain tau and amyloid ß proteins.
Ondrejcak T; Klyubin I; Hu NW; Yang Y; Zhang Q; Rodriguez BJ; Rowan MJ
Philos Trans R Soc Lond B Biol Sci; 2024 Jul; 379(1906):20230234. PubMed ID: 38853565
[TBL] [Abstract][Full Text] [Related]
4. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
[TBL] [Abstract][Full Text] [Related]
5. A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment.
Liu L; Orozco IJ; Planel E; Wen Y; Bretteville A; Krishnamurthy P; Wang L; Herman M; Figueroa H; Yu WH; Arancio O; Duff K
Neurobiol Dis; 2008 Jul; 31(1):46-57. PubMed ID: 18504134
[TBL] [Abstract][Full Text] [Related]
6. Enduring glucocorticoid-evoked exacerbation of synaptic plasticity disruption in male rats modelling early Alzheimer's disease amyloidosis.
Qi Y; Klyubin I; Ondrejcak T; Hu NW; Rowan MJ
Neuropsychopharmacology; 2021 Nov; 46(12):2170-2179. PubMed ID: 34188184
[TBL] [Abstract][Full Text] [Related]
7. Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies.
Zhang D; Qi Y; Klyubin I; Ondrejcak T; Sarell CJ; Cuello AC; Collinge J; Rowan MJ
Neuropharmacology; 2017 Jul; 121():231-246. PubMed ID: 28390893
[TBL] [Abstract][Full Text] [Related]
8. Pre-plaque Aß-Mediated Impairment of Synaptic Depotentiation in a Transgenic Rat Model of Alzheimer's Disease Amyloidosis.
Qi Y; Klyubin I; Hu NW; Ondrejcak T; Rowan MJ
Front Neurosci; 2019; 13():861. PubMed ID: 31474823
[TBL] [Abstract][Full Text] [Related]
9. Early Long-Term Memory Impairment and Changes in the Expression of Synaptic Plasticity-Associated Genes, in the McGill-R-Thy1-APP Rat Model of Alzheimer's-Like Brain Amyloidosis.
Habif M; Do Carmo S; Báez MV; Colettis NC; Cercato MC; Salas DA; Acutain MF; Sister CL; Berkowicz VL; Canal MP; González Garello T; Cuello AC; Jerusalinsky DA
Front Aging Neurosci; 2020; 12():585873. PubMed ID: 33551786
[TBL] [Abstract][Full Text] [Related]
10. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
11. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
12. NLRP3-dependent synaptic plasticity deficit in an Alzheimer's disease amyloidosis model in vivo.
Qi Y; Klyubin I; Cuello AC; Rowan MJ
Neurobiol Dis; 2018 Jun; 114():24-30. PubMed ID: 29477641
[TBL] [Abstract][Full Text] [Related]
13. Decreased circadian fluctuation in cognitive behaviors and synaptic plasticity in APP/PS1 transgenic mice.
He Y; Li Y; Zhou F; Qi J; Wu M
Metab Brain Dis; 2020 Feb; 35(2):343-352. PubMed ID: 31879834
[TBL] [Abstract][Full Text] [Related]
14. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.
Audrain M; Fol R; Dutar P; Potier B; Billard JM; Flament J; Alves S; Burlot MA; Dufayet-Chaffaud G; Bemelmans AP; Valette J; Hantraye P; Déglon N; Cartier N; Braudeau J
Mol Neurodegener; 2016 Jan; 11():5. PubMed ID: 26759118
[TBL] [Abstract][Full Text] [Related]
16. Chronic fornix deep brain stimulation in a transgenic Alzheimer's rat model reduces amyloid burden, inflammation, and neuronal loss.
Leplus A; Lauritzen I; Melon C; Kerkerian-Le Goff L; Fontaine D; Checler F
Brain Struct Funct; 2019 Jan; 224(1):363-372. PubMed ID: 30341742
[TBL] [Abstract][Full Text] [Related]
17. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
18. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
19. Chronic sleep deprivation exacerbates cognitive and synaptic plasticity impairments in APP/PS1 transgenic mice.
Wang C; Gao WR; Yin J; Wang ZJ; Qi JS; Cai HY; Wu MN
Behav Brain Res; 2021 Aug; 412():113400. PubMed ID: 34087256
[TBL] [Abstract][Full Text] [Related]
20. NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.
Wilson EN; Do Carmo S; Welikovitch LA; Hall H; Aguilar LF; Foret MK; Iulita MF; Jia DT; Marks AR; Allard S; Emmerson JT; Ducatenzeiler A; Cuello AC
J Alzheimers Dis; 2020; 73(2):723-739. PubMed ID: 31868669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
